XENE logo

Xenon Pharmaceuticals (XENE) Cash From Investing

Annual CFI

$165.00 M
+$276.38 M+248.13%

December 31, 2024


Summary


Performance

XENE Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherXENEcash flowmetrics:

Quarterly CFI

$98.50 M
+$96.52 M+4874.90%

December 31, 2024


Summary


Performance

XENE Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherXENEcash flowmetrics:

TTM CFI

$165.00 M
+$338.29 M+195.21%

December 31, 2024


Summary


Performance

XENE TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherXENEcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

XENE Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+248.1%0.0%0.0%
3 y3 years+166.9%+301.5%+168.6%
5 y5 years+349.2%+301.5%+168.6%

XENE Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+156.2%-11.0%+141.1%at high+133.2%
5 y5-yearat high+156.2%-11.0%+141.1%at high+133.2%
alltimeall timeat high+156.2%-11.0%+141.1%at high+133.2%

Xenon Pharmaceuticals Cash From Investing History

DateAnnualQuarterlyTTM
Dec 2024
$165.00 M(-248.1%)
$98.50 M(+4874.9%)
$165.00 M(-195.2%)
Sep 2024
-
$1.98 M(-98.2%)
-$173.29 M(+42.8%)
Jun 2024
-
$110.72 M(-339.6%)
-$121.39 M(-40.6%)
Mar 2024
-
-$46.20 M(-80.7%)
-$204.21 M(+83.3%)
Dec 2023
-$111.39 M(-62.0%)
-$239.79 M(-545.0%)
-$111.39 M(-195.5%)
Sep 2023
-
$53.88 M(+93.1%)
$116.67 M(-168.1%)
Jun 2023
-
$27.90 M(-40.2%)
-$171.31 M(-13.4%)
Mar 2023
-
$46.62 M(-497.2%)
-$197.90 M(-32.6%)
Dec 2022
-$293.40 M(+18.9%)
-$11.74 M(-95.0%)
-$293.40 M(-41.0%)
Sep 2022
-
-$234.10 M(<-9900.0%)
-$497.10 M(+100.9%)
Jun 2022
-
$1.32 M(-102.7%)
-$247.43 M(+2.9%)
Mar 2022
-
-$48.89 M(-77.3%)
-$240.55 M(-2.5%)
Dec 2021
-$246.77 M(+1366.8%)
-$215.43 M(-1483.2%)
-$246.77 M(-2180.3%)
Sep 2021
-
$15.57 M(+90.1%)
$11.86 M(-154.6%)
Jun 2021
-
$8.19 M(-114.9%)
-$21.75 M(+14.4%)
Mar 2021
-
-$55.10 M(-227.6%)
-$19.00 M(+13.0%)
Dec 2020
-$16.82 M(-74.6%)
$43.20 M(-339.6%)
-$16.82 M(-86.0%)
Sep 2020
-
-$18.03 M(-264.9%)
-$120.34 M(+27.3%)
Jun 2020
-
$10.93 M(-120.7%)
-$94.57 M(-15.7%)
Mar 2020
-
-$52.92 M(-12.3%)
-$112.13 M(+69.4%)
Dec 2019
-$66.21 M
-$60.32 M(-879.3%)
-$66.21 M(+258.9%)
Sep 2019
-
$7.74 M(-216.8%)
-$18.45 M(-62.8%)
Jun 2019
-
-$6.63 M(-5.4%)
-$49.53 M(+20.9%)
DateAnnualQuarterlyTTM
Mar 2019
-
-$7.00 M(-44.2%)
-$40.97 M(+41.3%)
Dec 2018
-$28.99 M(-219.3%)
-$12.56 M(-46.2%)
-$28.99 M(+172.7%)
Sep 2018
-
-$23.35 M(-1303.5%)
-$10.63 M(-184.1%)
Jun 2018
-
$1.94 M(-61.0%)
$12.63 M(-36.9%)
Mar 2018
-
$4.98 M(-14.2%)
$20.02 M(-17.6%)
Dec 2017
$24.29 M(-150.8%)
$5.80 M(-6620.2%)
$24.29 M(-276.9%)
Sep 2017
-
-$89.00 K(-101.0%)
-$13.73 M(-0.2%)
Jun 2017
-
$9.33 M(+0.9%)
-$13.76 M(-64.3%)
Mar 2017
-
$9.25 M(-128.7%)
-$38.51 M(-19.5%)
Dec 2016
-$47.84 M(-569.3%)
-$32.23 M(>+9900.0%)
-$47.84 M(+203.6%)
Sep 2016
-
-$111.00 K(-99.3%)
-$15.76 M(+127.1%)
Jun 2016
-
-$15.42 M(>+9900.0%)
-$6.94 M(-180.5%)
Mar 2016
-
-$83.00 K(-42.0%)
$8.62 M(-15.4%)
Dec 2015
$10.19 M(-414.2%)
-$143.00 K(-101.6%)
$10.19 M(-10.4%)
Sep 2015
-
$8.71 M(+6256.9%)
$11.38 M(-515.1%)
Jun 2015
-
$137.00 K(-90.8%)
-$2.74 M(+93.7%)
Mar 2015
-
$1.49 M(+43.4%)
-$1.42 M(-56.4%)
Dec 2014
-$3.24 M(-71.7%)
$1.04 M(-119.2%)
-$3.24 M(-24.3%)
Sep 2014
-
-$5.41 M(-469.7%)
-$4.28 M(-480.8%)
Jun 2014
-
$1.46 M(-532.8%)
$1.13 M(-432.8%)
Mar 2014
-
-$338.00 K
-$338.00 K
Dec 2013
-$11.47 M(-2436.5%)
-
-
Dec 2012
$491.00 K(-96.5%)
-
-
Dec 2011
$13.89 M
-
-

FAQ

  • What is Xenon Pharmaceuticals annual cash flow from investing activities?
  • What is the all time high annual CFI for Xenon Pharmaceuticals?
  • What is Xenon Pharmaceuticals annual CFI year-on-year change?
  • What is Xenon Pharmaceuticals quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Xenon Pharmaceuticals?
  • What is Xenon Pharmaceuticals quarterly CFI year-on-year change?
  • What is Xenon Pharmaceuticals TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Xenon Pharmaceuticals?
  • What is Xenon Pharmaceuticals TTM CFI year-on-year change?

What is Xenon Pharmaceuticals annual cash flow from investing activities?

The current annual CFI of XENE is $165.00 M

What is the all time high annual CFI for Xenon Pharmaceuticals?

Xenon Pharmaceuticals all-time high annual cash flow from investing activities is $165.00 M

What is Xenon Pharmaceuticals annual CFI year-on-year change?

Over the past year, XENE annual cash flow from investing activities has changed by +$276.38 M (+248.13%)

What is Xenon Pharmaceuticals quarterly cash flow from investing activities?

The current quarterly CFI of XENE is $98.50 M

What is the all time high quarterly CFI for Xenon Pharmaceuticals?

Xenon Pharmaceuticals all-time high quarterly cash flow from investing activities is $110.72 M

What is Xenon Pharmaceuticals quarterly CFI year-on-year change?

Over the past year, XENE quarterly cash flow from investing activities has changed by $0.00 (0.00%)

What is Xenon Pharmaceuticals TTM cash flow from investing activities?

The current TTM CFI of XENE is $165.00 M

What is the all time high TTM CFI for Xenon Pharmaceuticals?

Xenon Pharmaceuticals all-time high TTM cash flow from investing activities is $165.00 M

What is Xenon Pharmaceuticals TTM CFI year-on-year change?

Over the past year, XENE TTM cash flow from investing activities has changed by $0.00 (0.00%)